Arrhythmogenic effect of anti-arrhythmia drugs: incidence, possible mechanisms and therapeutic tactics
Abdalla, A.; Mazur, N.A.; Shestakova, N.V.; Sumarokov, A.B.
Kardiologiia 30(1): 95-100
1990
ISSN/ISBN: 0022-9040 PMID: 2186189 Document Number: 353544
Document emailed within 1 workday
Related Documents
Bagrov, A.I.; Veveris, M.M.; Ganelina, I.E.; Nikiforova, K.A.; Osipov, V.L.; Rukoiatkina, N.I.; Shtol'ba, P. 1991: Anti-arrhythmia effect of digoxin antibodies in experimental myocardial infarct (arrhythmogenic action of endogenous digoxin-like factor) Biulleten' Eksperimental'noi Biologii i Meditsiny 112(7): 20-22Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386
Kurbanov, R.D. 1991: Comparative characteristics of arrhythmogenic effects of anti-arrhythmia agents Kardiologiia 31(2): 92-95
Sokolov, S.F.; Golitsyn, S.P.; Malakhov, V.I.; Bankuzov, V.A.; Koltunova, M.I.; Golitsyn, L.S. 1990: The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor Farmakologiia i Toksikologiia 53(3): 57-60
Maslov, L.N.; Krylatov, A.V.; Lishmanov, I.B. 1996: Participation of endogenous mu- and delta-opiate receptor agonists in mechanisms of the anti-arrhythmia effect of adaptation Biulleten' Eksperimental'noi Biologii i Meditsiny 121(1): 24-25
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Adnan Abdalla; Mazur, N.A.; Shestakova, N.V. 1991: Mechanisms of interactions of anti-arrhythmia agents during their combined use Kardiologiia 31(2): 87-91
Chiche, P.; Domengie, B.; Benaim, R.; Calvo, G. 1975: New anti-arrhythmia drugs Semaine des Hopitaux. Therapeutique 51(10): 529-533
Balashov, V.P.; Sosunov, E.A.; Balykova, L.A.; Sernov, L.N. 1999: Study of various mechanisms of anti-arrhythmia activity of phosphoenol pyruvate Biulleten' Eksperimental'noi Biologii i Meditsiny 128(10): 414-416
Odenthal, H.J.; Wiechmann, H.W. 1987: Anti-arrhythmia drugs--administration and effectiveness Medizinische Monatsschrift für Pharmazeuten 10(12): 375-380
Hohnloser, S.H.; Zabel, M. 1991: Anti-arrhythmia drugs in geriatric patients Fortschritte der Medizin 109(25): 492-495
Ferrari, M.; Malini, P.L.; Padrini, R.; Costa, F.V.; Gobbato, S.; Ambrosioni, E. 1980: Clinical value of the determination of anti-arrhythmia drugs in the plasma Bollettino Della Societa Italiana di Cardiologia Suppl: 91-100
Jaillon, P.; Simon, T. 1992: Ventricular pro-arrhythmic effects of anti-arrhythmia drugs Therapie 47(3): 187-192
Zrenner, B.; Koller, B.; Rudolph, W. 1990: Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs? Herz 15(2): 90-102
Honerjäger, P.; Schmidt, G. 1993: Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 48(9): 425-429
Storozhuk, B.G. 1985: Anti-arrhythmia activity and side effects of various anti-arrhythmia agents Vrachebnoe Delo 3: 41-44
Mazurowa, A.; Szadowska, A.; Szmigielski, A. 1972: Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs Kardiologia Polska 15(2): 167-175
Witkowska, M. 1982: Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors Kardiologia Polska 25(2): 147-161
Steinbeck, G. 1992: Which patient with sustained ventricular tachycardia is suited for long-term therapy with anti-arrhythmia drugs? Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 47(5): 195-201
Kaverina, N.V.; Lyskovtsev, V.V.; Popova, E.P. 2003: Comparative study of electrophysiological mechanisms of anti-arrhythmia IIi class agents, cardiocyclide, nibentan, and sotalol during experimental myocardial infarction and sympathetic stimulation Eksperimental'naia i Klinicheskaia Farmakologiia 66(1): 27-33